Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects

被引：0
|
作者：
Karlsson, P [1 ]
Dencker, E [1 ]
Nyberg, S [1 ]
Mannaert, E [1 ]
Boom, S [1 ]
Talluri, K [1 ]
Rossenu, S [1 ]
Eriksson, B [1 ]
Eerdekens, M [1 ]
Farde, L [1 ]
机构：
[1] Karolinska Inst, Dept Clin Neurosci, Beerse, Belgium
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S386 / S386
页数：1
相关论文
共 50 条
  • [21] New hexahydrocarbazoles and spiro indoles, and their affinity for D2 dopamine and 5-HT2A serotonin receptors
    Fernández, F
    García-Mera, X
    Rodríguez, G
    Urrutia, A
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1999, 47 (07) : 1006 - 1009
  • [22] Effect of clozapine on the dimerization of serotonin 5-HT2A receptor and its genetic variant 5-HT2AH425Y with dopamine D2 receptor
    Lukasiewicz, Sylwia
    Faron-Gorecka, Agata
    Kedracka-Krok, Sylwia
    Dziedzicka-Wasylewska, Marta
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 659 (2-3) : 114 - 123
  • [23] Novel, highly potent and selective serotonin 5-HT2A/dopamine D2 receptor antagonists as potential antipsychotics.
    Lee, TK
    Robichaud, AJ
    Boyle, KE
    Lu, YM
    Chen, WT
    McClung, C
    Deng, W
    Miller, KJ
    McElroy, JF
    Largent, BL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U17 - U17
  • [24] Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia
    Akash Rathore
    Vivek Asati
    Mitali Mishra
    Ratnesh Das
    Varsha Kashaw
    Sushil Kumar Kashaw
    In Silico Pharmacology, 10 (1)
  • [25] HALLUCINOGENIC LIGAND (±)DOI MODULATE DOPAMINE D2 SIGNALING BY ACTIVATING 5-HT2A PROTOMERS OF A 5-HT2A/D2 HETEROOLIGOMER
    Gomez-Garcia, L.
    Gomez, S.
    Cadavid, M. I.
    Brea, J.
    Loza, M. I.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 70 - 71
  • [26] A PET study of 5-HT2 and D-2 dopamine receptor occupancy induced by olanzapine in healthy subjects
    Nyberg, S
    Farde, L
    Halldin, C
    NEUROPSYCHOPHARMACOLOGY, 1997, 16 (01) : 1 - 7
  • [27] Central 5-HT2A and D-2 dopamine receptor occupancy after sublingual administration of ORG 5222 in healthy men
    Andree, B
    Halldin, C
    VrijmoeddeVries, M
    Farde, L
    PSYCHOPHARMACOLOGY, 1997, 131 (04) : 339 - 345
  • [28] Anatomical relationships between serotonin 5-HT2A and dopamine D2 receptors in living human brain
    Ishii, Tatsuya
    Kimura, Yasuyuki
    Ichise, Masanori
    Takahata, Keisuke
    Kitamura, Soichiro
    Moriguchi, Sho
    Kubota, Manabu
    Zhang, Ming-Rong
    Yamada, Makiko
    Higuchi, Makoto
    Okubo, Yoshinori
    Suhara, Tetsuya
    PLOS ONE, 2017, 12 (12):
  • [29] REELIN INFLUENCES THE EXPRESSION AND FUNCTION OF DOPAMINE D2 AND SEROTONIN 5-HT2A RECEPTORS: A COMPARATIVE STUDY
    Varela, M. J.
    Lage, S.
    Caruncho, H. J.
    Cadavid, M. I.
    Loza, M. I.
    Brea, J.
    NEUROSCIENCE, 2015, 290 : 165 - 174
  • [30] Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density
    Lian, Jiamei
    Huang, Xu-Feng
    Pai, Nagesh
    Deng, Chao
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 47 : 62 - 68
12345